Η FDA ανέκλεισε σοκολάτες «σεξουαλικής ενίσχυσης» που περιείχαν κρυφά Viagra και Cialis, θέτοντας σε κίνδυνο την υγεία καταναλωτών, και προειδοποιεί για τους κινδύνους που εγκυμονεί η χρήση μη δηλωμένων φαρμακευτικών ουσιών σε «φυσικά» συμπληρώματα. #FDA #ΣεξουαλικήΕνίσχυση #ΑνακλήσειςΠροϊόντων
RT @RonFilipkowski: In the middle of the lunch, Trump called RFK Jr and Dr. Oz and told them he wanted the regulation lifted. Trump’s FDA C… #Trump #FDA #Regulation #Thetweetdoesnotmentionanyspecificcountries.Therefore #therearenocountrycodestoreturn.
Vrhovno sodišče v Sloveniji je ustavilo omejitve glede tabletk za splav, medtem ko je Trumpova administracija v ZDA dovolila uporabo tabletke za prekinitev nosečnosti, ki jo je odobrila Ameriška FDA. #TrumpovaAdministracija #FDA #PrekinitevNosečnosti

The U.S. Supreme Court has declined to block a FDA rule that allows the abortion pill mifepristone to be prescribed via telehealth and mailed, maintaining access to a medication used in over 60% of U.S. abortions, amidst ongoing legal challenges from several Republican-led states seeking to restrict its availability. #AbortionRights #Telehealth #FDARegulations #US #LA #TX #FL #MO #KS #ID #HI #VA #WV #NC #NY #CA

The U.S. Supreme Court has temporarily upheld a 2023 FDA rule allowing the abortion pill mifepristone to be prescribed via telehealth and mailed, despite ongoing legal challenges from conservative states aiming to restrict access to the medication. #AbortionRights #Telehealth #FDARegulations #US #LA #TX #FL #MO #KS #ID #HI #VA #WV #NC #NY #CA

U.S. cancer centers are rapidly trying to enroll patients in an early access program for daraxonrasib, a promising new pancreatic cancer drug from Revolution Medicines, following its FDA approval for expanded access after demonstrating a significant increase in survival rates in clinical trials. #PancreaticCancer #FDAApproval #CancerResearch #US #CA #NE

U.S. cancer centers are urgently enrolling patients in an early access program for Revolution Medicines' promising pancreatic cancer drug, daraxonrasib, following its recent FDA approval for expanded access, which comes after clinical trials showed it can double survival rates in advanced cases of the disease. #CancerResearch #FDAApproval #PancreaticCancer #US

U.S. cancer centers are urgently enrolling patients in an expanded access program for the promising pancreatic cancer drug daraxonrasib, which recently showed in clinical trials to significantly extend survival, while they await expected FDA approval amidst a surge of patient requests. #CancerResearch #FDAApproval #PancreaticCancer #US

U.S. cancer centers are rapidly trying to enroll patients in an early access program for Revolution Medicines' promising pancreatic cancer drug, daraxonrasib, following its FDA-approved expanded access due to its significant survival benefits demonstrated in clinical trials, amidst a surge of patient requests and logistical challenges in managing the program. #CancerResearch #FDAApproval #PancreaticCancer #US

U.S. cancer centers are rapidly enrolling patients in an early access program for daraxonrasib, a promising pancreatic cancer drug from Revolution Medicines, after the FDA approved the program following positive trial results that showed the drug doubled patient survival, while oncologists face logistical challenges in managing patient requests and navigating the approval process. #CancerResearch #FDAApproval #PancreaticCancer #US

The departure of U.S. FDA Commissioner Dr. Marty Makary is seen as a positive shift amid turmoil in the biotech sector, yet analysts warn that the lack of steady leadership may lead to increased volatility and unpredictability within the agency until a permanent replacement is appointed. #Biotech #FDA #Leadership #US

RT @RollingStone: Trump Taps Don Jr.’s 38-Year-Old Turkey-Hunting Pal to Lead FDA Kyle Diamantas is a lawyer, not a doctor, who will overs… #Trump #FDA #Leadership #TR #US
RT @RollingStone: Trump Taps Don Jr.’s 38-Year-Old Turkey-Hunting Pal to Lead FDA Kyle Diamantas is a lawyer, not a doctor, who will overs… #Trump #FDA #PoliticalAppointments #TR #US
On May 12, President Donald Trump announced the departure of Dr. Makary Marty as the head of the FDA, acknowledging the challenges he faced amid criticism over his opposition to flavored e-cigarette permits and abortion regulations, while confirming that Kyle Diamantas would serve as the interim leader until a permanent replacement is found. #FDA #TrumpAdministration #HealthPolicies #US #CN #GB

On May 12, President Donald Trump announced that Dr. Makary Marty, the head of the U.S. Food and Drug Administration (FDA), would resign after facing criticism over his opposition to flavored e-cigarettes and tightened abortion restrictions, with his deputy Kyle Diamantas set to take on the role temporarily. #TrumpAdministration #FDA #PublicHealth #US #CN #GB

El director de la FDA, Marty Makary, renunció tras semanas de presión de Trump por su desacuerdo sobre la autorización de cigarrillos electrónicos con sabor a frutas, que consideraba perjudicial para la salud de los jóvenes. #FDA #DonaldTrump #vapeo

Dr. Marty Makary resigned as the commissioner of the Food and Drug Administration amid pressure over his opposition to the authorization of fruit-flavored e-cigarettes, following a contentious tenure marked by clashes with powerful industries and criticism from public health leaders. #FDA #PublicHealth #Resignation #US
